n-(2-hydroxypropyl)methacrylamide has been researched along with docetaxel anhydrous in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 8 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bauer, H; Ghandehari, H; Greish, K; Grüner, M; Larson, N; Malugin, A; Naik, S; Pike, DB; Ray, A | 1 |
Bühler, P; Elsässer-Beile, U; Kopeček, J; Kopečková, P; Liu, J; Pan, H; Sima, M; Wolf, P | 1 |
Kopeček, J; Kopečková, P; Peng, ZH; Salama, ME; Sima, M | 1 |
Huang, Y; Li, L; Sun, W; Zhang, Z | 1 |
Barz, M; Brundel, P; Etrych, T; Hennink, WE; Hu, Q; Kiessling, F; Kostkova, H; Lammers, T; Prakash, J; Rijcken, CJ; Storm, G; van Gaal, E; Weber, B | 1 |
Dillon, C; Frazier, N; Ghandehari, H; Payne, A; Subrahmanyam, N | 1 |
Chytil, P; Etrych, T; Lidický, O; Říhová, B; Šírová, M; Strohalm, J; Tomala, J | 1 |
Huang, Y; Li, L; Wu, L; Yang, Q; Zhou, Z | 1 |
8 other study(ies) available for n-(2-hydroxypropyl)methacrylamide and docetaxel anhydrous
Article | Year |
---|---|
Comparison of active and passive targeting of docetaxel for prostate cancer therapy by HPMA copolymer-RGDfK conjugates.
Topics: Acrylamides; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Docetaxel; Male; Mice; Mice, Nude; Polymers; Prostatic Neoplasms; Taxoids | 2011 |
Prostate-cancer-targeted N-(2-hydroxypropyl)methacrylamide copolymer/docetaxel conjugates.
Topics: Acrylamides; Animals; Antibodies, Monoclonal; Antigens, Surface; Docetaxel; Drug Delivery Systems; Glutamate Carboxypeptidase II; Humans; Immunoconjugates; Iodine Radioisotopes; Male; Mice; Mice, Nude; Polymers; Prostatic Neoplasms; Taxoids; Tissue Distribution; Xenograft Model Antitumor Assays | 2012 |
Spacer length impacts the efficacy of targeted docetaxel conjugates in prostate-specific membrane antigen expressing prostate cancer.
Topics: Acrylamides; Adenocarcinoma; Animals; Antigens, Surface; Antineoplastic Agents; Cell Line, Tumor; Delayed-Action Preparations; Docetaxel; Drug Delivery Systems; Glutamate Carboxypeptidase II; Glutarates; Humans; Male; Mice; Mice, Nude; Molecular Weight; Oligopeptides; Polymers; Prostatic Neoplasms; Taxoids; Urea; Xenograft Model Antitumor Assays | 2013 |
Time-staggered delivery of docetaxel and H1-S6A,F8A peptide for sequential dual-strike chemotherapy through tumor priming and nuclear targeting.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Survival; Docetaxel; Female; HeLa Cells; Humans; Mice, Nude; Neoplasms; Peptides; Polymethacrylic Acids; Proto-Oncogene Proteins c-myc; Taxoids; Tumor Burden | 2016 |
Tailoring the physicochemical properties of core-crosslinked polymeric micelles for pharmaceutical applications.
Topics: Acrylamides; Cross-Linking Reagents; Docetaxel; Doxorubicin; Drug Carriers; Drug Liberation; Micelles; Molecular Weight; Polymers; Taxoids | 2016 |
Enhanced efficacy of combination heat shock targeted polymer therapeutics with high intensity focused ultrasound.
Topics: Acrylamides; Animals; Antineoplastic Agents; Cell Line, Tumor; Docetaxel; Drug Delivery Systems; Endoplasmic Reticulum Chaperone BiP; High-Intensity Focused Ultrasound Ablation; Humans; Hyperthermia, Induced; Male; Mice, Nude; Peptides; Prostate; Prostatic Neoplasms; Taxoids | 2017 |
The structure of polymer carriers controls the efficacy of the experimental combination treatment of tumors with HPMA copolymer conjugates carrying doxorubicin and docetaxel.
Topics: Acrylamides; Animals; Antineoplastic Agents; Cell Line, Tumor; Docetaxel; Doxorubicin; Drug Carriers; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasms; Taxoids | 2017 |
Subcellular co-delivery of two different site-oriented payloads for tumor therapy.
Topics: Acrylamides; Animals; Antineoplastic Agents; Apoptosis; Camptothecin; Cell Line, Tumor; DNA Damage; Docetaxel; Drug Delivery Systems; Humans; Male; Mice; Mice, Inbred BALB C; Micelles; Neoplasms; NIH 3T3 Cells; Organosilicon Compounds; Polymers; Taxoids; Tretinoin; Xenograft Model Antitumor Assays | 2017 |